Tagged with drugs
SaxoTV
#SaxoStrats: Buying Gilead Sciences ahead of Q4...
Saxo Bank’s Head of Equity Strategy Peter Garnry is looking to buy shares in Gilead Sciences...
SaxoTV
Earnings Season: GSK will disappoint but pharma...
Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...
SaxoTV
Are high returns from marijuana companies just...
This week the New York Times, in an editorial, urged US lawmakers to legalise marijuana. Some...
SaxoTV
Berger: Biogen's healthy recovery
Serge Berger suggests buying Biogen, a biotech firm which has reported sales of its Multiple...
SaxoTV
Garnry: "Astra Zeneca shareholders blew it"
AstraZeneca’s stock price tumbled 14 percent on Monday morning after the company rejected...
SaxoTV
Astra Zeneca and Pfizer: Five things you need...
As the Astra Zeneca Pfizer deal gets more bad tempered and political, what are the side effects...
SaxoTV
Pfizer-AstraZeneca: 'Deal will likely get done'
What next in the drama surrounding the proposed merger of pharmaceutical giants Pfizer and...